HIGHLIGHTS
- who: . and collaborators from the Nanjing Medical University, China have published the paper: A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer, in the Journal: (JOURNAL)
- what: The authors first analyzed necroptosis-related lncRNAs in cervical cancer, then constructed a novel signature based on necroptosis-related lncRNA, and finally investigated the prognostic value of the signature and its relationship with the immune microenvironment and treatment response in cervical cancer.
- how: Based on the 10 necroptosis-related lncRNAs frontiersin.org 10.3389/fgene.2022.938250 screened above . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.